Tibor Poruban

Dr. Tibor Poruban

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 October 2025 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
PFPavol Fülöp
Pavol Fülöp
ŠTŠtefan Tóth
Štefan Tóth
TPTibor Poruban
Tibor Poruban
ZFZuzana Fülöpová
Zuzana Fülöpová
ABAnna Borovská
Anna Borovská
MDMariana Dvoroznakova
Mariana Dvoroznakova
Background: Despite the availability of direct oral anticoagulants, warfarin remains essential for mechanical valves, renal impairment, and resource-limited settings. Traditional dosing achieves therapeutic range in only 55–65% of patients, increasing bleeding and thrombotic complications. This systematic review evaluates the literature on machine learning (ML) approaches for warfarin dose prediction (2022–2025). Methods: We analysed 14 studies encompassing 122,400 patients across nine countries following PRISMA guidelines. Studies utilizing ML algorithms for warfarin dosing with quantifiable performance metrics were included. Risk of bias was assessed using PROBAST. Results: Reinforcement learning demonstrated superior performance, achieving an 80.8% excellent responder ratio versus 41.6% for standard practice and 99.5% safety responder ratio versus 83.1%. Support vector machines achieved R2 up to 0.98 in homogeneous populations. Mean absolute error ranged from 0.11 to 1.8 mg/day, consistently outperforming traditional methods. Seven studies included external validation, whilst 78.6% were retrospective designs. Limited implementation studies showed therapeutic INR rates improving from 47.5% to 61.1%. Critically, only three studies (21.4%) reported any safety outcomes, with none adequately powered to detect differences in major bleeding events. Conclusions: While ML algorithms demonstrate improved dosing accuracy in retrospective analyses, the near-complete absence of adequately powered safety outcome data represents the primary barrier to clinical implementation. Without robust evidence on bleeding, thromboembolism, and mortality, the risk–benefit profile remains unknown. Implementation requires addressing: the predominance of retrospective studies (78.6%), limited prospective validation, restricted geographic diversity (43% from China), absence of African and South American studies, and no new Hispanic population data. Multicentre prospective trials with safety endpoints, population-specific validation, and interpretable models are essential before widespread clinical adoption can be recommended.

31 May 2023 in Wiener klinische Wochenschrift
Verified
Journal Article
Closed access
PDF file
TPTibor Poruban
Tibor Poruban
MHMikulas Hunavy
Mikulas Hunavy
DFDaniel Farkas
Daniel Farkas
SCStanislav Carnoky
Stanislav Carnoky
MJMarta Jakubova
Marta Jakubova

1 January 2026 in Diagnostics
Verified
Journal Article
Open access
PDF file
ŠTŠtefan Tóth
Štefan Tóth
MVMarianna Vachalcova
Marianna Vachalcova
KBKamil Barbierik
Kamil Barbierik
AJAdriana Jarolimkova
Adriana Jarolimkova
PFPavol Fülöp
Pavol Fülöp
TPTibor Poruban
Tibor Poruban
Background/Objectives: Cardiovascular (CV) diseases remain the leading cause of morbidity and mortality across Europe. Despite substantial progress in prevention, diagnostics, and therapeutics, outpatient cardiology care continues to face systemic challenges, including limited consultation time, workforce constraints, and incomplete clinical information at the point of care. The primary objective of this study is threefold. First, to evaluate whether AI-enhanced telemedicine improves clinical control of hypertension, dyslipidemia, and heart failure compared to standard ambulatory care. Second, to assess the impact on physician workflow efficiency and documentation burden through AI-assisted clinical documentation. Third, to determine patient satisfaction and safety profiles of integrated telemedicine–AI systems. Clinical control will be measured by a composite endpoint of disease-specific targets assessed at the 12-month follow-up visit. Methods: The TeleAI-CVD Concept Study aims to evaluate the integration of telemedicine and artificial intelligence (AI) to enhance the efficiency, quality, and individualization of cardiovascular disease management in the ambulatory setting. Within this framework, AI-driven tools will be employed to collect structured clinical histories and current symptomatology from patients prior to outpatient visits using digital questionnaires and conversational interfaces. Results: Obtained data, combined with telemonitoring metrics, laboratory parameters, and existing clinical records, will be synthesized to support clinical decision-making. Conclusions: This approach is expected to streamline consultations, increase diagnostic accuracy, and enable personalized, data-driven care through continuous evaluation of patient trajectories. The anticipated outcomes of the TeleAI-CVD study include the development of optimized, AI-assisted management protocols for cardiology patients, a reduction in unnecessary in-person visits through effective telemedicine-based follow-up, and accelerated attainment of therapeutic targets. Ultimately, this concept seeks to redefine the paradigm of outpatient cardiovascular care by embedding advanced digital technologies within routine clinical workflows.

26 August 2024 in The Egyptian Heart Journal
Verified
Journal Article
Open access
PDF file
TPTibor Poruban
Tibor Poruban
MSMartin Studencan
Martin Studencan
PKPeter Kirsch
Peter Kirsch
RNRobert Novotny
Robert Novotny
Background: Takotsubo cardiomyopathy (TTC) is an acute and usually reversible condition that often mimics the course of acute coronary syndrome (ACS), making it particularly challenging to differentiate, especially in the initial phases. In this study, we retrospectively analyzed the incidence, clinical course, examination results, and in-hospital mortality of TTC in patients with ACS hospitalized at our cardiology center from January 2018 to October 2023. Results: During the study period, a total of 3835 selective coronary angiograms were urgently performed at our facility, with a diagnosis of TTC established in 52 (1.35%) patients, the majority of whom were females—48 (93%), with an average age of 64.2 ± 10.2 years. Stress-induced mechanisms were identified in 36 (69%) patients. The most common symptom was chest pain (86.5%). Electrocardiographic changes primarily included ST-segment elevations (61.6%) and depressions (14%). The average left ventricular ejection fraction was 45.1 ± 8.3 (33–57%), typically with an echocardiographic pattern of apical ballooning dysfunction followed by midventricular dyskinesia. In-hospital mortality was zero. Conclusions: TTC is a reversible condition with a low incidence of complications. Its occurrence in our patient cohort is lower compared to international registries. However, as demonstrated in this study, it is associated with significant in-hospital morbidity.

12 June 2024 in Archives of Medical Science
Verified
Journal Article
Open access
DPDominik Pella
Dominik Pella
TPTibor Poruban
Tibor Poruban
JGJozef Gonsorcik
Jozef Gonsorcik
JFJan Fedacko
Jan Fedacko
Zuzana PellaZuzana Pella
Zuzana Pella
MVMarianna Vachalcova
Marianna Vachalcova
Introduction: The growing interest in Vitamin D deficiency as a potential contributor to coronary artery disease (CAD) has prompted increased scrutiny. Nevertheless, its status as a confirmed risk factor remains unestablished. This study seeks to explore the connection between serum vitamin D levels and CAD.Material and methods: Employing a cross-sectional approach, 205 patients eligible for coronary computed tomography angiography (CCTA) were chosen. Serum vitamin D levels were assessed and juxtaposed with the outcomes of CCTA, which encompassed the coronary artery calcium score (CACS), as well as the presence and severity of coronary artery involvement attributed to atherosclerotic plaques.Results: The average age of the participants was 61.4±10.8 years, and the mean serum vitamin D level was 19.6±10.3 ng/dl (ranging from 4.7 to 39.7 ng/dl). In total, 52.1% of the participants (n=107) exhibited vitamin D deficiency, 35.1% (n=72) had insufficient levels, and 12.6% (n=26) had sufficient levels of vitamin D. The mean serum vitamin D level was notably lower in patients with severe coronary artery disease (CAD) (P<0.0001). According to the Spearman test, a significant negative correlation (-0.48) was identified between the serum vitamin D level and CACS (P<0.0001). Conversely, the mean CACS in the vitamin D deficient group was significantly higher than in the insufficient and sufficient vitamin D groups (P<0.0001 for both comparisons).Conclusions: There was a correlation between vitamin D deficiency and both CACS and the severity of coronary artery stenosis.

1 January 2024 in Brazilian Journal of Cardiovascular Surgery
Verified
Journal Article
Open access
ISIngrid Schusterova
Ingrid Schusterova
PAPanagiotis Artemiou
Panagiotis Artemiou
IGIvo Gasparovic
Ivo Gasparovic
TPTibor Poruban
Tibor Poruban
MVMarianna Barbierik Vachalcova
Marianna Barbierik Vachalcova
PZPavol Zenuch
Pavol Zenuch
Introduction: Aortic valve replacement (AVR) is often recommended for patients with severe aortic stenosis or chronic aortic regurgitation. These conditions result in remodeling of the left ventricle, including increased interstitial fibrosis that may persist even after AVR. These structural changes impact left ventricular (LV) mechanics, causing compromised LV diameter to occur earlier than reduced LV ejection fraction (LVEF). The aim of this study was to examine the effect of left ventricular end -diastolic diameter (LVEDD) and its role in aortic expansion one year after AVR. Methods: Sixty-three patients who underwent AVR were evaluated. All patients underwent standard transthoracic echocardiography, which included measurements of the ascending aorta, aortic root, LVEF, and LVEDD before the surgery and one year postoperatively. Correlations between these variables were calculated. Results:All patients underwent AVR with either a mechanical or biological prosthetic aortic valve. Following AVR, there was a significant decrease in the dimensions of the ascending aorta and aortic root (both P=0.001). However, no significant changes were observed in LVEDD and LVEF. Correlations were found between the preoperative ascending aortic size and the preoperative and one-year postoperative LVEDD (r=0.419, P=0.001 and r=0.320, P=0.314, respectively). Additionally, there was a correlation between the postoperative ascending aortic size and the preoperative and one-year postoperative LVEDD (r=0.320, P=0.003 and r=0.136, P=0.335, respectively). Conclusion: The study findings demonstrate a significant correlation between the size of the aortic root and ascending aorta, before and after AVR. Additionally, a notable correlation was observed between postoperative LVEDD and the size of the aortic root.